The ODC activity on DLD1 and SW620 tumors was further confirmed by IHC analysis of tumor heterogeneity (H&E), tumor endothelium (CD31), or by fluorescence staining for proliferating tumor cells (Ki67). This evidence concerns the gene MKI67 and neoplasm.